Pulse Biosciences's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.23.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.92.
During the past 3 years, the average EBIT per Share Growth Rate was 25.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 14.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pulse Biosciences's EBIT per Share or its related term are showing as below:
PLSE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.5 Med: -3.75 Max: 25
Current: 25
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Pulse Biosciences was 25.00% per year. The lowest was -55.50% per year. And the median was -3.75% per year.
PLSE's 3-Year EBIT Growth Rate is ranked better than 72.06% of 723
companies
in the Medical Devices & Instruments industry
Industry Median: 6.7
vs PLSE: 25.00
The historical data trend for Pulse Biosciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulse Biosciences (NAS:PLSE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pulse Biosciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of Pulse Biosciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulse Biosciences (Pulse Biosciences) Business Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLSE has been successfully added to your 